Akkaya D

References (3)

Title : In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease - Akkaya_2024_Drug.Dev.Res_85_e22184
Author(s) : Akkaya D , Seyhan G , Sari S , Barut B
Ref : Drug Dev Res , 85 :e22184 , 2024
Abstract :
PubMedSearch : Akkaya_2024_Drug.Dev.Res_85_e22184
PubMedID: 38634273

Title : Azole derivatives inhibit wildtype butyrylcholinesterase and its common mutants - Sari_2023_Drug.Dev.Res__
Author(s) : Sari S , Onder S , Akkaya D , Sabuncuoglu S , Zengin M , Barut B , Karakurt A
Ref : Drug Dev Res , : , 2023
Abstract :
PubMedSearch : Sari_2023_Drug.Dev.Res__
PubMedID: 37154110

Title : Antifungal azole derivatives featuring naphthalene prove potent and competitive cholinesterase inhibitors with potential CNS penetration according to the in vitro and in silico studies - Sari_2022_Chem.Biodivers__
Author(s) : Sari S , Akkaya D , Zengin M , Sabuncuoglu S , Ozdemir Z , Alagoz MA , Karakurt A , Barut B
Ref : Chem Biodivers , : , 2022
Abstract :
PubMedSearch : Sari_2022_Chem.Biodivers__
PubMedID: 35695705